Belantamab Mafodotin Combination Therapy
A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination With Iberdomide (CC-220)/Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma
Near Add Your Location
Sorting 35 by
- Not currently accepting
- Show Principal Investigator
Mary Greeley Medical Center
Ames, IA
- Not currently accepting
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsMcFarland Clinic PC
Ames, IA
- Not currently accepting
McFarland Clinic PC (Boone)
Boone, IA
- Not currently accepting
McFarland Clinic Trinity Cancer Center
Fort Dodge, IA
- Not currently accepting
McFarland Clinic PC (Jefferson)
Jefferson, IA
- Not currently accepting
McFarland Clinic PC (Marshalltown)
Marshalltown, IA
- Not currently accepting
- Not currently accepting
Tufts Medical Center Cancer Center
Boston, MA
- Not currently accepting
Columbus Oncology and Hematology Associates
Columbus, OH
- Not currently accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.